Skip to main content
. 2019 Mar 28;58(14):2003–2008. doi: 10.2169/internalmedicine.2361-18

Table 4.

Examinations at the Diagnosis of Intestinal Tuberculosis, Treatment and Clinical Course.

Case Sputum AFB smear Specimen of culture positive IGRA Pulmonary TB Pulmonary cavity Anti-TB treatment Operation after ITB diagnosis Prognosis
1 (-) sputum NE (+) (-) HREZ enterectomy (colon cancer) improved
2 (-) sputum, stool T (+) (+) (-) HRS improved
3 (-) intestinal tissue T (+) (-) (-) HREZ improved
4 (+) sputum Q (+) (+) (+) HREZ enterectomy (ileus) improved
5 (-) sputum Q (+) (+) (-) HREZ improved
6 (+) sputum, stool Q (-) (+) (+) HREZ death
7 (-) sputum Q (-) (+) (-) HREZ improved
8 (+) sputum Q (+) (+) (-) HREZ enterectomy (ileus) improved
9 (+) sputum, stool Q (+) (+) (+) HRSZ adhesiotomy (ileus) improved
10 (-) intestinal tissue Q (-) (-) (-) HREZ improved

AFB: acid-fast bacilli, TB: tuberculosis, IGRA: interferon gamma release assay, ITB: intestinal tuberculosis, NE: not examined, T: T-SPOT. TB, Q: QuantiFERON TB-Gold, H: isoniazid, R: rifampicin, E: ethambutol, Z: pyrazinamide, S: streptomycin